Skip to main content
CLXClorox Company (The)Sell4.6·$86.84
SellHigh Confidence
Investment thesis

Clorox has a credible earnings beat track record and solid peer-relative standing, but the stock has run into a natural ceiling with less than 3% of room remaining to the consensus target, free cash flow conversion is critically weak at 8% of net income, and a confirmed downtrend with a death cross in place argues for patience rather than new exposure.

Thesis pillars

  • Free Cash Flow Quality Concern→Stable
  • Confirmed Downtrend Blocks Entry↑Improving
  • Limited Upside To Consensus Ceiling↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Aug 7, 2026

Full reasoning →

Open full analysis

Clorox Company (The) (CLX) Stock Analysis

Recovery setup

SellVALUE-TRAP 1/5ShortHigh Confidence

Consumer Defensive · Household & Personal Products

Earnings in 4 days (2026-11-02). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Analyst target reached at $86.84 — A.R:R is negative (-0.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole source or single-source suppliers.

The Clorox Company, founded in Oakland in 1913, makes consumer and professional products including Clorox, Pine-Sol, Glad, Fresh Step, Kingsford, Hidden Valley, Brita and Burt's Bees, plus Purell after the April 2026 GOJO acquisition. It reported fiscal 2026 net sales of $6.7... Read more

$86.84-0.1% A.UpsideScore 4.6/10#17 of 18 Household & Personal Products
QualityF-score4 / 9FCF yield1.05%
IncomeYield5.72%(5y avg 3.47%)Payout103.12%at-risk
Stop $82.54Analyst target $86.72(reached)A.R:R -0.0:1
Analyst consensus$96.35+11.0%17 analysts
$86.84price
$96.35mean
$74
$154

Sell if holding. Analyst target reached at $86.84 — A.R:R is negative (-0.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole source or single-source suppliers. Chart setup: Death cross but MACD improving, RSI 63. Score 4.6/10, high confidence.

Passes 6/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 4d<=7d. Suitability: moderate.

10-K grounded · weekly refresh

About Clorox Company (The)

About Clorox Company (The)

The Clorox Company reported fiscal 2026 net sales of $6.7 billion, with Walmart Stores, Inc. and its affiliates at 26% of consolidated net sales and the five largest customers together at about half. The company employs about 9,200 people, operates in approximately 25 countries or territories, and sells in approximately 95 markets. Over 80% of its sales come from brands holding the No. 1 or No. 2 market share position in their categories, and cleaning products were 44% of net sales in each of fiscal 2026 and 2025.

Clorox sells through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, e-commerce channels and distributors. The portfolio includes Clorox cleaning and disinfecting products, Pine-Sol, Liquid-Plumr, Glad bags and wraps, Fresh Step cat litter, Kingsford grilling products, Hidden Valley dressings, Brita water filtration and Burt's Bees, plus professional lines such as CloroxPro and Clorox Healthcare. In April 2026 the company completed the acquisition of GOJO, which now operates as Clorox Purell and adds a B2B distribution network and a large installed base of dispensing systems. Diluted EPS fell 26% in fiscal 2026 on lower net sales and higher manufacturing and logistics costs, after an ERP system implementation, completed in January 2026, pulled certain sales into the prior year. The venture agreement with Procter & Gamble for Glad expired January 31, 2026, requiring the company to purchase P&G's 20% interest at fair value. Key raw materials include resins, non-woven fabrics for wipes and sodium hypochlorite, and the filing says some suppliers are sole source or single-source.

Show full overview

Retailer and supplier concentration form the central lens. The 10-K shows Walmart at 26%, 27% and 25% of net sales across fiscal 2026, 2025 and 2024, spread across all reportable segments, and no other customer reached 10%. Because the five largest customers account for about half of net sales, shifts in their shelf space, pricing demands or inventory timing could weigh on results, as the ERP-related retailer pre-orders in fiscal 2025 illustrated. Interruptions in deliveries from sole-source or single-source suppliers could adversely impact the company.

See also: Consumer Defensive · Household & Personal Products

From Clorox Company (The)'s most recent 10-K filing, extracted October 18, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Nov 2, 20264d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Consumer Defensive): +0.8
Strong earnings beat streak (3/4)
Risks
Concentration risk — Supplier: sole source or single-source suppliers
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8)

Key Metrics

P/E (TTM)18.1
P/E (Fwd)14.2
Mkt Cap$10.5B
EV/EBITDA14.1
Profit Mgn8.7%
ROE163.8%
Rev Growth-2.0%
Beta0.57
Dividend5.72%
Rating analysts27

Quality Signals

Piotroski F4/9

Options Flow

P/C1.25bearish
IV46%normal
Max Pain$45-48.2% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomerWalmart Stores largest customer26%
    10-K Item 1: 'Walmart Stores, Inc. and its affiliates, were 26%, 27% and 25% of consolidated net sales for each of the fiscal years ended June 30, 2026, 2025 and 2024'
  • MEDIUMCustomerfive largest customers
    10-K Item 1: 'five largest customers accounted for about half of the'
  • HIGHSuppliersole source or single-source suppliers
    10-K Item 1: 'some of which are sole source or single-source suppliers'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Revenue shrinking — -2.0% YoY. Growth thesis broken unless recovery story develops.static

Earnings Growth
0.0
Revenue Growth
2.0
Declining revenue: -2%

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
0.6
Bollinger
1.7
52w Position
4.0

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.1
Value Rank
6.7
Quality Rank
7.5
Attractive P/E vs peersSuperior ROE vs peers
GatesA.R:R -0.0=NEGATIVEEARNINGS PROXIMITY 4d<=7dDeath cross (50MA < 200MA)Momentum 6.2>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
63 · Neutral
↑ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $77.99Resistance $87.43

Price Targets

A.Upside-0.1%
A.R:R-0.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-0.1% upside)
! Negative risk/reward — downside exceeds upside
! EARNINGS_PROXIMITY:4d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-02 (4d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLX stock a buy right now?

Sell if holding. Analyst target reached at $86.84 — A.R:R is negative (-0.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: sole source or single-source suppliers. Chart setup: Death cross but MACD improving, RSI 63. Prior stop was $82.54. Score 4.6/10, high confidence.

What is the CLX stock price target?

Analyst target $86.72 reached (−0.1% from $86.84); no take-profit level is published. Prior stop was $82.54. Stop-loss: $82.54.

What are the risks of investing in CLX?

Concentration risk — Supplier: sole source or single-source suppliers; Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.8).

Is CLX overvalued or undervalued?

Clorox Company (The) trades at a P/E of 18.1 (forward 14.2). TrendMatrix value score: 6.4/10. Verdict: Sell.

What do analysts say about CLX?

27 analysts cover CLX with a consensus score of 2.7/5. Average price target: $96.

What does Clorox Company (The) do?The Clorox Company, founded in Oakland in 1913, makes consumer and professional products including Clorox, Pine-Sol,...

The Clorox Company, founded in Oakland in 1913, makes consumer and professional products including Clorox, Pine-Sol, Glad, Fresh Step, Kingsford, Hidden Valley, Brita and Burt's Bees, plus Purell after the April 2026 GOJO acquisition. It reported fiscal 2026 net sales of $6.7 billion and sells in approximately 95 markets, mainly through mass retailers. Walmart was 26% of net sales, and the five largest customers about half.

Related stocks: SPB (Spectrum Brands Holdings, Inc.) · ELF (e.l.f. Beauty, Inc.) · NWL (Newell Brands Inc.) · IPAR (Interparfums, Inc.) · KVUE (Kenvue Inc.)
Home › Stocks › CLX

Latest news

Latest News

Yahoo Finance92d ago
MarketBeat92d ago
TradingKey92d ago
TradingKey92d ago
Yahoo Finance92d agoEarnings
Yahoo Finance92d agoEarnings
TradingView183d agoEarnings
MarketBeat190d agoAnalyst
GuruFocus93d ago
MarketBeat93d ago
Sahm93d agoEarnings
Seeking Alpha184d ago
GuruFocus191d agoAnalyst
MarketBeat191d ago
Seeking Alpha191d ago
TradingView91d agoEarnings
MarketBeat91d ago
MarketBeat91d ago
StockStory182d agoEarnings
MarketWatch182d ago
Loading more...